"At the Helen G. Nassif Community Cancer Center, we think about cancer care differently. We surround patients, survivors and caregivers alike with the resources they need to fight cancer."

During the past decade, Helen G Nassif Community Cancer Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Helen G Nassif Community Cancer Center" #1 collaborator was "National Cancer Institute (NCI)" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Helen G Nassif Community Cancer Center" are "Breast Cancer" (1 trials) and "Lung Cancer" (1 trials). Many other conditions were trialed in "Helen G Nassif Community Cancer Center" in a lesser frequency.

Most popular intervention types in "Helen G Nassif Community Cancer Center" are "Drug" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cyclophosphamide" (1 trials), "Docetaxel" (1 trials), "Doxorubicin" (1 trials), "Paclitaxel" (1 trials) and "carboplatin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Helen G Nassif Community Cancer Center" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Helen G Nassif Community Cancer Center". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Helen G Nassif Community Cancer Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Helen G Nassif Community Cancer Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".